257
In e na ional Jou nal o Ad ance and Applied Resea ch
www.ijaa .co.in
ISSN – 2347-7075
Impac Fac o – 8.141
Pee Re iewed
Bi-Mon hly
Vol. 6 No. 38
Sep embe - Oc obe - 2025
AI-D i en Heal hca e: Diagnosis ,P edic i e Analy ics o Disease Diagnosis
and Telemedicine
Poonam P amod Shilwan
Assis an P o esso , Compu e Science,
D .D.Y.Pa il A s, Comme ce And Science College, Aku di, Pune-44
Co esponding Au ho – Poonam P amod Shilwan
DOI - 10.5281/zenodo.17315696
Abs ac :
The inco po a ion o A i icial In elligence (AI) in o heal hca e has opened up a ans o ma i e
e a o p edic i e analy ics in disease diagnosis and ea men . By ha nessing la ge olumes o medical
da a, AI-powe ed p edic i e models u ilize sophis ica ed machine lea ning and deep lea ning me hods
o de ec pa e ns and o ecas heal h ou comes. This echnology no only imp o es he accu acy o
diagnoses bu also acili a es ea ly disease de ec ion and ailo s ea men plans o indi idual pa ien s,
ul ima ely enhancing pa ien ca e and making heal hca e deli e y mo e e icien . AI sys ems d aw om
a ied da a sou ces such as elec onic heal h eco ds (EHRs), medical imaging, and gene ic p o iles,
o e ing a holis ic iew o pa ien heal h. Howe e , he adop ion o AI in heal hca e is no wi hou
obs acles, including conce ns o e da a p i acy, he necessi y o ex ensi e high-quali y da ase s, and
he challenge o seamlessly in eg a ing AI ools in o cu en clinical p ocesses. This abs ac p o ides
an o e iew o he ad ancemen s in AI-d i en heal hca e p edic i e analy ics, ou lines signi ican
achie emen s, and examines he hu dles and u u e p ospec s o i s applica ion in diagnosing and
ea ing diseases. By o e coming hese challenges, AI holds he p omise o e olu ionize heal hca e by
making i mo e p edic i e, accu a e, and pe sonalized.
Keywo ds: A i icial In elligence, Heal hca e Analy ics, Da a Pa e ns, P edic i e Modeling
In oduc ion:
The eme gence o A i icial
In elligence (AI) in heal hca e has
e olu ionized con en ional medical p ac ices,
in oducing inno a i e me hods o disease
diagnosis and ea men . AI-d i en p edic i e
analy ics le e ages ad anced algo i hms and
machine lea ning echniques o p ocess as
and complex medical da ase s, e ealing
pa e ns ha may elude adi ional analysis.
These echnologies ha e shown g ea po en ial
in enhancing diagnos ic p ecision, an icipa ing
disease de elopmen , and enabling he
c ea ion o pe sonalized ea men plans—
ul ima ely leading o imp o ed pa ien
ou comes and mo e e icien u iliza ion o
heal hca e esou ces. In ecen yea s, he
heal hca e sec o has seen a apid inc ease in
AI adop ion, ueled by signi ican
ad ancemen s in da a p ocessing capabili ies
and he g owing a ailabili y o la ge-scale
medical da a.A i icial In elligence (AI)
models possess he capaci y o in eg a e and
analyze he e ogeneous da a sou ces, including
elec onic heal h eco ds (EHRs), medical
imaging, and genomic da a, he eby p o iding
a comp ehensi e and uni ied pe spec i e on
pa ien heal h. Such mul idimensional analysis
enhances clinical decision-making by enabling
he ea ly iden i ica ion o heal h isks and
acili a ing imely in e en ions, which can
con ibu e o educ ions in bo h mo bidi y and
IJAAR Vol. 6 No. 38 ISSN – 2347-7075
Poonam P amod Shilwan
258
mo ali y. Despi e he conside able po en ial o
AI in heal hca e, i s implemen a ion is
accompanied by se e al challenges. These
include conce ns ega ding da a p i acy and
secu i y, he necessi y o high-quali y,
anno a ed da ase s, and he di icul y o
in eg a ing AI sys ems seamlessly in o
es ablished clinical wo k lows. Fu he mo e,
ensu ing he eliabili y, in e p e abili y, and
e hical applica ion o AI echnologies is
essen ial o os e ing us and p omo ing
widesp ead adop ion among heal hca e
p ac i ione s and pa ien s alike.
This pape p o ides a comp ehensi e
o e iew o he cu en s a e o AI-d i en
p edic i e analy ics in heal hca e, wi h a
pa icula ocus on ecen echnological
ad ancemen s and hei applica ions in disease
diagnosis and ea men . I also add esses he
key challenges ha mus be o e come o ully
ha ness he po en ial o AI wi hin clinical
se ings. By examining hese aspec s, he s udy
aims o unde sco e he ans o ma i e ole o
AI in os e ing a mo e p edic i e, p ecise, and
pe sonalized heal hca e pa adigm, he eby
laying he g oundwo k o u u e inno a ions
and enhanced pa ien ou comes.
Rela ed Wo k:
The applica ion o A i icial
In elligence (AI) in heal hca e p edic i e
analy ics has eme ged as a c i ical a ea o
esea ch, pa icula ly in he domains o disease
diagnosis, isk s a i ica ion, and pe sonalized
ea men . Se e al p ominen s udies and
ini ia i es ha e signi ican ly ad anced he
ield, e lec ing i s mul idisciplina y and
e ol ing na u e.
1. DeepMind Heal h:
DeepMind, a subsidia y o Alphabe
Inc., has made subs an ial con ibu ions o AI
in clinical p ac ice. No ably, i s esea ch on
ea ly de ec ion algo i hms o condi ions such
as diabe ic e inopa hy and acu e kidney inju y
has demons a ed he po en ial o AI o
imp o e diagnos ic accu acy and enable imely
clinical in e en ions. These e o s unde sco e
he alue o AI in enhancing pa ien ou comes
h ough ea ly and accu a e disease p edic ion.
2. IBM Wa son Heal h:
IBM Wa son Heal h has been a he
o e on o le e aging machine lea ning and
na u al language p ocessing (NLP) o assis
clinicians in decision-making. I s capabili ies
in ex ac ing ele an insigh s om bo h
s uc u ed and uns uc u ed clinical da a ha e
b oadened he scope o AI applica ions,
pa icula ly in oncology and ch onic disease
managemen . Wa son’s NLP-d i en sys ems
exempli y he in eg a ion o AI in o complex
heal hca e da ase s o suppo e idence-based
ca e.
3. Medical Image Analysis:
AI-d i en medical image analysis has
seen apid ad ancemen , wi h deep lea ning
models achie ing nea -human o human-le el
pe o mance in asks such as umo de ec ion,
lesion segmen a ion, and disease classi ica ion.
Collabo a i e e o s by o ganiza ions like he
Radiological Socie y o No h Ame ica
(RSNA) and leading academic ins i u ions
ha e accele a ed he de elopmen o AI ools
ha augmen adiological and pa hological
diagnos ics.
4. Genomic Medicine:
In he ield o genomic medicine, AI
has been pi o al in in e p e ing la ge-scale
gene ic da a o iden i y disease-associa ed
a ian s and in o m pe sonalized he apies.
Ini ia i es such as he UK Biobank and he All
o Us Resea ch P og am ha e acili a ed he
c ea ion o comp ehensi e da ase s ha
suppo AI-d i en app oaches o p edic i e
modeling, isk assessmen , and p e en i e
heal hca e.
IJAAR Vol. 6 No. 38 ISSN – 2347-7075
Poonam P amod Shilwan
259
5. Elec onic Heal h Reco d (EHR) Analysis:
AI echniques applied o elec onic
heal h eco ds (EHRs) ha e signi ican ly
imp o ed capabili ies in disease p edic ion,
pa ien s a i ica ion, and ea men
op imiza ion. Resea ch e o s ha e ocused on
de eloping models ha can syn hesize
s uc u ed da a (e.g., lab esul s) and
uns uc u ed da a (e.g., physician no es) o
deli e ac ionable clinical insigh s, he eby
suppo ing mo e in o med and e icien ca e
deli e y.
6. Clinical Decision Suppo Sys ems
(CDSS):
AI-enhanced Clinical Decision
Suppo Sys ems (CDSS) a e being designed
o assis heal hca e p o ide s ac oss diagnos ic
and he apeu ic pa hways. These sys ems
in eg a e pa ien da a wi h clinical guidelines
and medical li e a u e, enabling dynamic,
con ex -awa e decision-making. Recen
s udies highligh he po en ial o AI-d i en
CDSS o educe diagnos ic e o s and
s anda dize high-quali y ca e.
7. E hical Conside a ions in AI-D i en
Heal hca e:
As AI becomes mo e deeply
embedded in heal hca e sys ems, e hical
conside a ions ha e gained p ominence. Key
issues include pa ien p i acy, in o med
consen , algo i hmic bias, and model
anspa ency. Schola s and egula o y bodies
ha e emphasized he need o comp ehensi e
e hical amewo ks and go e nance models o
ensu e esponsible de elopmen , equi able
deploymen , and sus ained us in AI
echnologies.
Me hodology:
The de elopmen o AI-d i en
p edic i e analy ics o disease diagnosis and
ea men in heal hca e in ol es a sys ema ic
and mul i-phase p ocess. This me hodology
encompasses da a acquisi ion, p ep ocessing,
ea u e enginee ing, model de elopmen ,
e alua ion, in e p e a ion, deploymen , and
alida ion. Each phase is c i ical o ensu ing
he eliabili y, accu acy, and clinical
applicabili y o he esul ing AI models.
1. Da a Collec ion:
The ounda ion o p edic i e analy ics lies
in acqui ing di e se, high-quali y da ase s.
These may include:
● Elec onic Heal h Reco ds (EHRs):
S uc u ed and uns uc u ed clinical da a,
such as diagnoses, lab esul s,
medica ions, and physician no es.
● Medical Imaging: Radiological images
(e.g., X- ays, CT, MRI) used o image-
based diagnos ics.
● Genomic Da a: In o ma ion om genome
sequencing and omics da a o
pe sonalized medicine.
● Wea able De ices: Real- ime
physiological and beha io al da a (e.g.,
hea a e, ac i i y le els).
● Pa ien Su eys and Clinical T ials:
Sel - epo ed heal h me ics and ou comes.
All da a collec ion mus adhe e o da a
go e nance, secu i y, and p i acy s anda ds
such as HIPAA o GDPR, ensu ing e hical and
law ul use o pa ien da a.
2. Da a P ep ocessing:
P ep ocessing is essen ial o ensu ing
da a quali y and model eadiness. S eps
include:
● Da a Cleaning: Remo ing e o s,
duplica es, and inconsis encies.
● Missing Da a Handling: Impu a ion o
emo al based on he missingness
mechanism.
● Ou lie De ec ion: Iden i ying and
ea ing anomalies ha may bias model
lea ning.
● No maliza ion/S anda diza ion:
T ans o ming da a o a consis en scale.
IJAAR Vol. 6 No. 38 ISSN – 2347-7075
Poonam P amod Shilwan
260
● Fea u e Enginee ing: C ea ing new
ea u es om aw da a ha be e ep esen
he unde lying p oblem and imp o e
model pe o mance.
3. Fea u e Selec ion:
In o ma i e ea u es a e selec ed using
me hods such as:
● Co ela ion Analysis: Measu ing
ela ionships be ween a iables.
● Fea u e Impo ance Ranking: Using
model-based me hods (e.g., ee-based
models).
● Dimensionali y Reduc ion: Techniques
like PCA o -SNE o educe noise and
imp o e aining e iciency.
● Clinical Rele ance: P io i izing ea u es
ha a e meaning ul in a medical con ex .
4. Model De elopmen :
Model selec ion and de elopmen a e
guided by he p oblem ype (classi ica ion,
eg ession, e c.) and da a cha ac e is ics.
Common app oaches include:
● T adi ional Machine Lea ning
Algo i hms: Logis ic eg ession, decision
ees, andom o es s, suppo ec o
machines (SVM), g adien boos ing
machines (e.g., XGBoos ).
● Deep Lea ning A chi ec u es:
Con olu ional Neu al Ne wo ks (CNNs)
o imaging da a, Recu en Neu al
Ne wo ks (RNNs) o Long Sho -Te m
Memo y (LSTM) ne wo ks o empo al
da a.
● Model T aining in ol es hype pa ame e
uning (e.g., g id sea ch, andom sea ch),
egula iza ion (L1/L2), d opou , ba ch
no maliza ion, and po en ially ensemble
me hods o ans e lea ning o imp o e
gene aliza ion.
5. Model E alua ion:
Models a e e alua ed using mul iple
me ics o ensu e obus pe o mance:
● Classi ica ion Me ics: Accu acy,
p ecision, ecall, F1-sco e, and A ea
Unde he Recei e Ope a ing
Cha ac e is ic Cu e (AUC-ROC).
● Valida ion Techniques: K- old c oss-
alida ion, holdou alida ion, and
s a i ied sampling.
● Robus ness Tes ing: Sensi i i y analysis
o examine how model pe o mance a ies
wi h inpu changes o da a noise.
6. In e p e abili y and Explainabili y:
In e p e able AI is essen ial o
clinical accep ance. Techniques include:
● Fea u e Impo ance Sco es: Quan i ying
a iable in luence.
● SHAP (SHapley Addi i e
Explana ions): P o iding consis en ,
local, and global in e p e abili y.
● LIME (Local In e p e able Model-
agnos ic Explana ions): Explaining
p edic ions on a pe -ins ance basis.
Ensu ing model anspa ency helps
clinicians unde s and and us AI-d i en
decisions, acili a ing adop ion in p ac ice.
7. Deploymen and In eg a ion:
Once alida ed, models mus be
in eg a ed in o clinical sys ems:
● Deploymen Pla o ms: Cloud-based o
on-p emise sys ems o eal- ime use.
● Use In e aces: Designing in ui i e
dashboa ds o applica ions o clinicians.
● Sys em In eg a ion: Aligning wi h EHR
pla o ms and hospi al in o ma ion
sys ems (HIS).
● Pe o mance Moni o ing: Implemen ing
sys ems o de ec concep d i , da a d i ,
and main ain model accu acy o e ime.
8. Clinical Valida ion and T ials:
Be o e widesp ead use, AI sys ems
mus unde go igo ous clinical alida ion:
● Real-Wo ld Tes ing: P ospec i e s udies
and clinical ials o assess e ec i eness.
IJAAR Vol. 6 No. 38 ISSN – 2347-7075
Poonam P amod Shilwan
261
● S akeholde Engagemen : Collabo a ion
wi h clinicians, e hicis s, egula o y
bodies, and pa ien s.
● Regula o y Compliance: Adhe ing o
s anda ds om bodies such as he FDA,
EMA, o local heal h au ho i ies.
Conclusion:
The in eg a ion o A i icial
In elligence (AI) in o heal hca e p edic i e
analy ics is eshaping con en ional me hods o
disease diagnosis and ea men . Th ough he
use o ad anced machine lea ning and deep
lea ning echniques, AI-powe ed sys ems a e
posi ioned o signi ican ly enhance pa ien ca e
by enabling ea ly disease de ec ion, suppo ing
he c ea ion o pe sonalized ea men
s a egies, and imp o ing o e all clinical
ou comes. The me hodology unde pinning AI-
d i en heal hca e p edic i e analy ics ollows
a s uc u ed app oach ha encompasses da a
collec ion, p ep ocessing, model de elopmen ,
e alua ion, and deploymen . By u ilizing
he e ogeneous da ase s—including elec onic
heal h eco ds (EHRs), medical imaging
eposi o ies, genomic da abases, and da a om
wea able de ices—AI models a e capable o
unco e ing clinically ele an pa e ns and
gene a ing insigh s ha suppo in o med
decision-making. No able ad ancemen s in
his ield include he c ea ion o p edic i e
algo i hms o ea ly de ec ion o condi ions
such as diabe ic e inopa hy and acu e kidney
inju y, as well as he use o na u al language
p ocessing (NLP) echniques o ex ac
aluable in o ma ion om uns uc u ed
clinical ex . Addi ionally, AI has
demons a ed nea -human o e en supe io
pe o mance in medical image analysis asks
such as umo de ec ion and disease
classi ica ion. Howe e , he widesp ead
adop ion o hese echnologies aces se e al
challenges, including conce ns o e da a
p i acy, algo i hmic ai ness, and he seamless
in eg a ion o AI ools in o exis ing clinical
wo k lows. E hical conside a ions—
pa icula ly hose ela ed o anspa ency,
accoun abili y, and equi able access—a e
equally c i ical o ensu ing he esponsible
deploymen o AI in heal hca e se ings.
In conclusion, AI-d i en p edic i e
analy ics p esen signi ican oppo uni ies o
ad ancing disease diagnosis and ea men
wi hin heal hca e. By sys ema ically
add essing exis ing challenges and applying
he me hodological app oaches discussed in
his pape , esea che s and heal hca e
o ganiza ions can e ec i ely le e age he
ans o ma i e capabili ies o AI o os e a
mo e p edic i e, p ecise, and pe sonalized
heal hca e ecosys em. The success ul
in eg a ion o hese echnologies p omises no
only o enhance clinical decision-making and
pa ien ou comes bu also o op imize
heal hca e deli e y. Ongoing esea ch,
in e disciplina y collabo a ion, and adhe ence
o e hical and egula o y s anda ds will be
c i ical o unlocking he ull po en ial o AI
and shaping he u u e o mode n medicine.
Re e ences:
1. Rajkoma , A., Dean, J., & Kohane, I.
(2019). Machine Lea ning in Medicine.
New England Jou nal o Medicine,
380(14), 1347-1358.DOI:
10.1056/NEJM a1814259
2. Obe meye , Z., & Emanuel, E. J.
(2016). P edic ing he Fu u e - Big
Da a, Machine Lea ning, and Clinical
Medicine. New England Jou nal o
Medicine, 375(13), 1216-1219. DOI:
10.1056/NEJMp1606181
3. Es e a, A., Kup el, B., No oa, R. A.,
Ko, J., Swe e , S. M., Blau, H. M., &
Th un, S. (2017). De ma ologis -le el
classi ica ion o skin cance wi h deep
IJAAR Vol. 6 No. 38 ISSN – 2347-7075
Poonam P amod Shilwan
262
neu al ne wo ks. Na u e, 542(7639),
115-118DOI: 10.1038/na u e21056
4. Johnson, A. E., Polla d, T. J., Shen, L.,
Lehman, L. W., Feng, M., Ghassemi,
M., ... & Ma k, R. G. (2016). MIMIC-
III, a eely accessible c i ical ca e
da abase. Scien i ic Da a, 3, 160035.
DOI: 10.1038/sda a.2016.35
5. Gulshan, V., Peng, L., Co am, M.,
S umpe, M. C., Wu, D.,
Na ayanaswamy, A., ... & Kim, R.
(2016). De elopmen and alida ion o
a deep lea ning algo i hm o de ec ion
o diabe ic e inopa hy in e inal undus
pho og aphs. JAMA, 316(22), 2402-
2410. DOI: 10.1001/jama.2016.17216
